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1. Introduction
   Diabetes mellitus (DM) is a group of metabolic diseases 
characterized by hyperglycemia resulting from defects 
in insulin secretion, insulin action, or both[1]. With a 
disturbing global prevalence of 285 million people in 
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Objective: To investigate the phenolic compounds composition and the inhibitory activity of 
Mangifera indica (M. indica) and Mucuna urens (M. urens) seeds extracts against some key enzymes 
(α-amylase, α-glucosidase and aldose reductase) implicated in the pathology and complications of 
type 2 diabetes in vitro.
Methods: Reverse phase chromatographic quantification of the major flavonoids and phenolic 
acids in the seeds extracts was carried out using high performance liquid chromatography coupled 
with diode array detection. The inhibitory activities of the seeds extracts against α-amylase and 
α-glucosidase were estimated using soluble starch and ρ-nitrophenylglucopyranoside as their 
respective substrates. Inhibition of aldose reductase activity by the extracts was assayed using 
partially purified lens homogenate of normal male rat as source of enzyme; inhibition of Fe2
+
-
induced lipid peroxidation by extracts was tested in rat pancreas homogenate.
Results: The chromatography result revealed that extracts of both seeds had appreciable levels of 
some major flavonoids and phenolic acids of pharmacological importance, including gallic acid, 
chlorogenic acid, caffeic acid, ellagic acid, catechin, rutin, quercitrin, quercetin and kaempferol. 
Extracts of both seeds effectively inhibited α-amylase, α-glucosidase and aldose reductase 
activities in a dose-dependent manner, having inhibitory preference for these enzymes in the order 
of aldose reductase>α-glucosidase>α-amylase. With lower half-maximal inhibitory concentrations 
(IC50) against α-amylase, α-glucosidase, and aldose reductase, M. indica had stronger inhibitory 
potency against these enzymes than M. urens. Extracts of both seeds also inhibited Fe2
+
-induced 
lipid peroxidation in a dose-dependent pattern, with M. indica being more potent than M. urens.
Conclusions: The results obtained provide support for a possible use of M. indica and M. urens 
seeds in managing hyperglycemia and preventing the complications associated with it in type 2 
diabetes.
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2010 (that is, 6.4% of the world population), and a projected 
increase to 439 million people by 2030 (that is, 7.7% of the 
world population)[2], DM is nearing a pandemic. About 90% 
to 95% of diabetic cases are diagnosed with type 2 diabetes 
(T2D)[3].
   T2D is characterized by chronic hyperglycemia due to 
insulin resistance and loss of pancreas β-cell function[4]. 
Hyperglycemia and the complications associated with it are 
threats to the life of T2D patients. Diabetic hyperglycemia 
stimulates other factors that facilitate the progression 
of diabetic complications such as retinopathy and 
nephropathy[5]. For instance, under hyperglycemic condition, 
the saturation of hexokinase necessitates the channeling 
of glucose to the polyol pathway in which aldose reductase 
reduces glucose to sorbitol, which is subsequently reduced 
to fructose by sorbitol dehydrogenase.
   Currently available antidiabetic drugs, such as acarbose, 
in addition to not being effective in maintaining euglycemia, 
usually present with some side effects. Hence, there is 
increasing emphasis on the use of plant products rich in 
phenolic compounds that could be more effective for the 
management of T2D with less side effects. In addition to 
their effectiveness and safety, herbal remedies could be 
a cheaper alternative to the synthetic antidiabetic drugs. 
Consequently, the World Health Organization recommended 
that further research on the antidiabetic effects of medicinal 
plants should be carried out[6].
   Phenolic compounds are part of the secondary metabolites 
that constitute the active principles in plant products. These 
active ingredients are responsible for the therapeutic and/
or pharmacological activities, such as antidiabetic effects, 
of medicinal plants[7]. Phenolic compounds are known 
to modulate glucose metabolism by several mechanisms 
including inhibition of carbohydrate digesting enzymes and 
aldose reductase[8,9].
   The inhibition of carbohydrate metabolizing enzymes 
such as α-amylase and α-glucosidase retards the digestion 
carbohydrates and the subsequent absorption of glucose, 
leading to a decrease in postprandial blood glucose level[8]. 
Furthermore, the inhibition of aldose reductase activity has 
been reported to be an effective pharmacological approach 
to prevent certain complications of diabetes[10].
   Mangifera indica L. (M. indica) (mango) and Mucuna 
urens L. (M. urens) (horse eye bean) seeds both have uses 
that range from local soup additives as thickeners[11,12] 
to ethnomedicinal applications[13,14]. The phytochemical 
composition and antioxidant activities of seeds extracts of 
these two plants had earlier been reported[15]. To further 
explore the pharmacological potentials of these two plants, 
this study investigated the phenolic composition and the 
in vitro inhibitory activity of M. indica and M. urens seeds 
extracts against some key enzymes linked to the pathology 
and complications of T2D.
2. Materials and methods
2.1. Sample collection and preparation
   Samples of M. indica and M. urens seeds were purchased 
from a farm settlement in Ibadan, Oyo State, Nigeria. The 
seeds were later authenticated at the Department of Botany, 
University of Ibadan, Nigeria. Subsequently, the seeds were 
sorted, sun-dried, manually shelled and milled to a fine 
particle size. Milled samples were packed in airtight vials 
and stored at 4 °C until analysis.
   All the chemicals used for analysis were of analytical 
grade.
2.2. Preparation of seed methanol extract
   Sample powder (2 g) was extracted by steeping in 100 mL of 
methanol for 1 h with continuous shaking using a mechanical 
shaker. The supernatant, subsequently referred to as methanol 
extract, was collected after centrifuging at 3 000 r/min for 
10 min, and stored at -4 °C for further analysis. Methanol 
extract for carbohydrate hydrolyzing enzymes inhibition 
assays was concentrated to dryness, and redissolved in 
equal volume of dimethyl sulfoxide.
2.3. Handling of experimental animal
   The Wister strain albino rats used in this study were 
handled in accordance with the Guide for the Care and Use 
of Laboratory Animals, as approved by the Animal Ethics 
Committee of our institution. Adult male rats weighing 200-
250 g were procured from the experimental animal breeding 
unit of Department of Veterinary Medicine, University of 
Ibadan, Nigeria.
2.4. Quantification of phenolic compounds using high 
performance liquid chromatography coupled with diode array 
detection (HPLC-DAD)
   The HPLC-DAD instrumentation comprised a Shimadzu 
Prominence Auto Sampler (SIL-20A)  HPLC system 
(Shimadzu, Kyoto, Japan), equipped with Shimadzu LC-20AT 
reciprocating pumps connected to a DGU 20A5 degasser with 
a CBM 20A integrator, SPD-M20A diode array detector and LC 
solution 1.22 SP1 software.
   Reverse phase chromatographic quantification of the 
major phenolic compounds in M. indica and M. urens 
seeds extracts was carried out at a concentration of 20 mg/
mL under gradient conditions using C18 column (4.6 mm
伊150 mm) packed with 5 µm diameter particles; the 
mobile phase was water containing 1% formic acid (A) 
and acetonitrile (B), and the composition gradient was: 
13% of B until 10 min and changed to obtain 20%, 30%, 50%, 
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60%, 70%, 20% and 10% B at 20, 30, 40, 50, 60, 70 and 80 min, 
respectively, following the method described by Kamdem 
et al. with slight modifications[16]. Samples extracts and 
mobile phase were filtered through 0.45 µm membrane filter 
(Millipore) and then degassed by ultrasonic bath prior to use. 
The flow rate was 0.7 mL/min, injection volume 50 µL and the 
wavelength were 257 nm for gallic acid, 281 nm for catechin, 
325 nm for chlorogenic, caffeic and ellagic acids, and 366 
nm for quercetin, quercitrin, rutin and kaempferol. Stock 
solutions of standards references were prepared in the HPLC 
mobile phase at a concentration range of 0.030-0.250 mg/mL 
for kaempferol, quercetin, quercitrin, rutin and catechin, and 
0.050-0.450 mg/mL for ellagic, gallic, caffeic and chlorogenic 
acids. Chromatography peaks were confirmed by comparing 
its retention time with those of reference standards and 
by DAD spectra (200 to 600 nm). Both the sample extracts 
and the standards were analyzed in triplicates. Calibration 
curves obtained for the standards were as follows: gallic 
acid: Y=13 569x+1 276.2 (r=0.999 6); chlorogenic acid: 
Y=13 054x+1 267.5 (r=0.999 8); ellagic acid: Y=12 832x+1 246.3 
(r=0.999 5); catechin: Y=12 783x+1 257.9 (r=0.999 7); caffeic acid: 
Y=12 480x+1 275.2 (r=0.999 3); quercitrin: Y=13 405x+1 264.7 
(r=0.999 9); rutin: Y=11 983x+1 271.3 (r=0.999 8); quercetin: 
Y=12 683x+1 292.5 (r=0.999 6) and kaempferol: Y=12 539x+1 183.0 
(r=0.999 7).
2.5. α-amylase inhibition assay
   α-amylase inhibition assay was carried out according to 
the method described by Kwon et al[17]. Appropriate dilutions 
of the extract amounting to 500 µL, and 500 µL of 0.02 mol/
L sodium phosphate buffer (pH 6.9 with 0.006 mol/L sodium 
chloride) containing α-amylase solution (0.5 mg/mL) were 
incubated at 37 °C for 10 min. After pre-incubation, 500 µL of 
1% starch solution in 0.02 mol/L sodium phosphate buffer was 
added. The reaction mixture was then incubated at 37 °C 
for 15 min and the reaction was terminated with 1.0 mL of 
dinitrosalicylic acid color reagent (1% 3, 5-dinitrosalicylic 
acid and 12% sodium potassium tartrate in 0.4 mol/L NaOH). 
The reaction mixture was then incubated in a boiling water 
bath for 5 min, cooled to room temperature, and diluted 
with 10 mL distilled water. The absorbance was measured 
at 540 nm. Percentage α-amylase inhibition was calculated 
using the formula:
Inhibition (%)= [(A540control-A540sample)/A540control]伊100
   The IC50 was calculated from the dose-inhibition non-
linear regression curve of each extract.
2.6. α-glucosidase inhibition assay
   The inhibitory effect of extracts against α-glucosidase 
activity was determined according to the method described 
by Kim et al.[18], using α-glucosidase from Bacillus 
stearothermophilus. Briefly, 5 units of α-glucosidase 
were pre-incubated with 20 µg/mL of the different seeds 
methanol extracts for 15 min. About 3 mmol/L para-
nitrophenylglucopyranoside (PNPG) dissolved in 20 mmol/
L phosphate buffer, pH 6.9 was added as a substrate to start 
the reaction. The reaction mixture was further incubated at 
37 °C for 20 min and stopped by addition of 2 mL of 0.1 mol/
L Na2CO3. The α-glucosidase activity was determined by 
measuring the yellow colored p-nitrophenol released from 
PNPG at 400 nm. Each test was performed in triplicates and 
the mean absorption was used to calculate percentage 
α-glucosidase inhibition as follows:
Inhibition (%)=[(A400control-A400sample)/A400control]伊100
   The IC50 was calculated from the dose-inhibition non-
linear regression curve of each extract.
2.7. Aldose reductase inhibition assay
   Normal male rats weighing 200-250 g were used for 
the preparation of partially purified rat lens aldose 
reductase following a procedure adapted from Hayman and 
Kinoshita[19]. Briefly, lenses were quickly removed from rats 
following euthanasia with ether, and homogenized in a glass 
homogenizer with a Teflon pestle in 5 volume of ice-cold 
distilled water. The homogenate was centrifuged at 10 000 r/
min at 0-4 °C for 20 min. The supernatant was precipitated 
with saturated ammonium sulfate at 40%, 50% and then 
at 75% salt saturation. The supernatant was retained after 
the first two precipitations. The pellet from the last step, 
possessing aldose reductase activity, was dispersed in 75% 
ammonium sulfate and subsequently used for the inhibition 
assay.
   Inhibition of aldose reductase activity was assayed by 
estimating the consumption of NADPH at 340 nm as described 
by Da Settimo et al[20]. The reaction mixture contained 4.67 
mmol/L D,L-glyceraldehyde as a substrate, 0.11 mmol/L 
NADPH, 0.067 mol/L phosphate buffer, pH 6.2 and 0.05 mL 
of the enzyme preparation in a total volume of 1.5 mL. The 
reference blank contained all the above reagents except the 
substrate D,L-glyceraldehyde to correct for the oxidation 
of NADPH not associated with reduction of the substrate. 
The enzyme reaction was initiated by addition of D,L-
glyceraldehyde and was monitored for 4 min after an initial 
period of 1 min at 30 °C. A decrease in absorbance of test 
relative to the control at 340 nm is a function amount of 
NADPH consumed. Hence:
Inhibition (%)= [(A340control-A340sample)/A340control]伊100
   The IC50 was estimated from the dose-inhibition non-
linear regression curve of each extract.
2.8. Lipid peroxidation inhibition assay
   The ability of the methanol extracts to inhibit Fe2
+
-induced 
lipid peroxidation in rat pancreas homogenate was assayed 
according to the modified method of Ohkawa et al[21]. To 
prepare the low-speed pancreas supernatant used for the 
assay, normal male rats weighing 200-250 g were mildly 
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anaesthetized in ether; the pancreas were rapidly excised and 
placed in ice. Then 10% (w/v) pancreas homogenate prepared 
by homogenizing the pancreas in cold saline, was centrifuged 
for 10 min at 1 400 r/min to yield a pellet that was discarded 
and the low-speed supernatant (S1). To a reaction mixture 
containing 100 µL of S1 fraction, 30 µL of 0.1 mol/L Tris-HCl 
buffer (pH 7.4) and different concentrations of plants methanol 
extracts, 30 µL of freshly prepared 25 µmol/L Fe2
+
 solution was 
added to initiate lipid peroxidation. The volume was made up 
to 300 µL with deionized water before incubation at 37 °C for 1 
h. The color reaction was initiated by adding 300 µL of 81 g/L 
sodium duodecyl sulphate to the reaction mixture containing 
the S1, followed by the addition of 600 µL of acetic acid/
HCl (pH 3.4) and 600 µL of 0.8% (v/v) thiobarbituric acid. This 
mixture was incubated at 100 °C for 1 h. The absorbance of 
thiobarbituric acid reactive species produced were measured 
at 532 nm in an UV-visible spectrophotometer. Appropriate 
controls of each plant extract and the positive control were 
carried out. 
2.9. Statistical analysis
   Results of triplicate experiments were expressed as mean
依SD. Analysis of variance (ANOVA) and least significance 
difference (LSD) were carried out on the result data at 95% 
confidence level using SPSS statistical software package, 
version 17.
3. Results
   The phenolics (flavonoids and phenolic acids) composition 
of M. indica and M. urens seeds as quantified using HPLC-
DAD is presented in Table 1. The result showed that both seeds 
had high levels of some major flavonoids and phenolic acids of 
pharmacological importance, including gallic acid, catechin, 
chlorogenic acid, caffeic acid, ellagic acid, rutin, quercitrin, 
quercetin and kaempferol (Figure 1). Gallic acid, chlorogenic 
acid, caffeic acid, quercitrin, quercetin and kaempferol were 
significantly (P<0.05) higher in M. urens than in M. indica. In 
contrast, M. indica had significantly (P<0.05) higher level of 
rutin than M. urens. The levels of catechin and ellagic acid 
were comparable (P>0.05) in both seeds.
Table 1
Major phenolics composition of M. indica and M. urens by HPLC-DAD.
Phenolic compounds (mg/g) M. indica M. urens









Caffeic acid  9.97依0.03
b 15.73依0.01
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Kaempferol  3.87依0.02b 11.06依0.03
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Results are expressed as mean依SD of triplicate determinations. Values with 
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Figure 1. Representative HPLC chromatograms of M. indica and M. urens 
seed extracts.
Gallic acid (peak 1), catechin (peak 2), chlorogenic acid (peak 3), caffeic acid 
(peak 4), ellagic acid (peak 5), rutin (peak 6), quercitrin (peak 7), quercetin 
(peak 8) and kaempferol (peak 9).
   Table 2 shows the IC50 values of M. indica and M. urens 
extracts against α-amylase, α-glucosidase, aldose reductase 
and Fe2
+
-induced lipid peroxidation. The results revealed 
that both extracts inhibited α-amylase, α-glucosidase and 
aldose reductase, in a dose-dependent pattern as shown in 
Figures 2-4. The IC50 values of M. indica extract against each 
of these three enzymes were consistently lower than those of 
M. urens. This was an indication that M. indica had a more 
potent inhibitory ability against α-amylase, α-glucosidase 
and aldose reductase activity than M. urens. The result 
further showed that both extracts displayed inhibitory 
preference against the activities of these three enzymes in 
the order of aldose reductase>α-glucosidase>α-amylase. 
Similarly, extracts of both seeds inhibited lipid peroxidation 
induced by iron (II) in rat pancreas homogenate in a dose-
dependent manner (Figure 5); however, M. indica was more 
effective than M. urens as indicated by its lower IC50 value.
Table 2
Half-maximal inhibitory concentration (IC50) of M. indica and M. 
urens seeds extracts against α-amylase, α-glucosidase, aldose 
reductase activities and lipid peroxidation.
IC50 (mg/mL) M. indica M. urens
α-amylase 0.71 1.13
α-glucosidase 0.34 0.52
Aldose reductase 0.27 0.42
Lipid peroxidation 0.10 0.16
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4. Discussion
   There has been increasing interest in the use of plant-
derived hypoglycemic agents for the management of 
T2D and its complications in the recent time due to 
the side effects associated with the use of synthetic 
hypoglycemic drugs. In addition to the side effects, 
synthetic hypoglycemic drugs have other limitations such 
as development of resistance, irresponsiveness in some 
patient population, and inability to effectively control the 
hyperlipidemia that usually presents with T2D[22].
   Phenolic compounds possess pharmacological activities 
including antidiabetic effects. In this study, two classes 
of pharmacologically important phenolic compounds 
were quantified, namely, flavonoids and phenolic acids. 
Flavonoids are synthesized from phenylalanine[23], and 
are widely distributed in the plant kingdom. Prominently, 
flavonoids have continued to receive increasing attention 
because of their health benefits as antioxidants in the 
prevention of human diseases[24]. In addition to their 
antioxidant properties, as natural drugs, flavonoids are 
known to possess antihyperglycemic activity[25], protect 
against the development of diabetes[26,27], and ameliorate 
the complications of diabetes[28,29]. Other reported 
pharmacological activities of flavonoids include antiallergic, 
antiinflammatory, hepato- and gastro-protective, antiviral, 
and antineoplastic activities[30].
   The flavonoids quantified in the extracts were catechin, 
rutin, quercitrin, quercetin and kaempferol. Of these 
flavonoids, quercetin and rutin are consumed more 
abundantly in foods[31]. Rutin is known to possess various 
pharmacological activities including antihyperglycemic[25]. 
Similarly, quercetin has been reported to exhibit 
antidiabetic activity[32], and alleviate diabetic nephropathy 
in streptozotocin-diabetic rats[33]. Interestingly, the levels of 
quercetin quantified in both M. indica and M. urens seeds 
(1 180 mg/kg and 10 170 mg/kg respectively) in this study are 
over 1 000 times larger than the level (generally below 10 
mg/kg) in the edible parts of vegetables[34]. The phenolic 
acids of pharmacological importance quantified were 
gallic acid, caffeic, chlorogenic and ellagic acid. Caffeic 
acid is regarded as the most common phenolic compounds 
distributed in the plant flora followed by chlorogenic 
acid[35]. Research has shown that plants containing these 
phenolic acids exhibit antidiabetic activity[36,37]. Catechins, 
for example, have been reported to possess inhibitory 
properties against α-glycosidase and α-amylase in vitro[38].
   Postprandial blood glucose level depends partly on the 
activities of carbohydrate hydrolyzing enzymes, mainly, 
α-amylase and α-glucosidase, that break down dietary 
starch and sugars into glucose[39]. α-amylase is present 
in the saliva and pancreatic juice, and is responsible 
for cleaving the α-1,4 bonds of starch releasing dextrin, 
maltose, and maltotriose[40]. The glycosidic linkages of 
Figure 2. Concentration-inhibition curve of M. indica and M. urens seed 























M. indica M. urens
Extract concentration (mg/mL)
0               0.05           0.1             0.15             0.2           0.25            0.3
Figure 3. Concentration-inhibition curve of M. indica and M. urens seed 
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Figure 4. Concentration-inhibition curve of M. indica and M. urens seed 
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Figure 5. Concentration-inhibition curve of M. indica and M. urens 
seed extracts against Fe2
+
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these oligosaccharides are subsequently hydrolyzed by 
α-glucosidase present in the ciliary membrane of small 
intestine to produce glucose molecules which are then 
absorbed[41]. Consequently, the inhibition of α-amylases 
and α-glucosidases activities is one of the most effective 
approaches to control hyperglycemia in type 2 diabetic 
patients[18].
   P lant-derived phenol ic  compounds have the 
potential to inhibit both α-amylase and α-glucosidase, 
making them natural pharmacological agents for the 
management of postprandial hyperglycemia and its 
associated complications[42]. The results obtained in this 
study revealed that extracts of M. indica and M. urens 
seeds potently inhibited the activities of α-amylase, 
α-glucosidase and aldose reductase. Of interest is their 
inhibitory preference for these three enzymes which was in 
the order of aldose reductase>α-glucosidase>α-amylase. 
The stronger inhibition of α-glucosidase over α-amylase 
by both extracts observed in this study could confer them 
with the pharmacological advantage of lesser clinical side 
effects than acarbose and other synthetic oral hypoglycemic 
drugs currently used to manage hyperglycemia in diabetic 
patients. In contrast to this observed inhibitory preference, 
acarbose has been reported to inhibit both α-amylase and 
α-glucosisidase[43], but with preference for pancreatic 
α-amylase[44]. This excessive inhibition of α-amylase 
underlies the clinical side effects of acarbose including 
diarrhea, flatulence and abdominal discomfort[17,44]. 
This finding is in agreement with the report of Kwon et 
al.[17] that unlike acarbose, plant-derived α-amylase 
and α-glucosidase inhibitors have a stronger inhibitory 
effect against α-glucosidase activity than α-amylase 
activity. Diarrhea in diabetic patients could exacerbate 
their nutritional status through loss of both essential and 
nonessential nutrients, and body fluids.
   The inhibitory effect of plant extracts against aldose 
reductase activity is a possible therapeutic approach to 
ameliorate diabetic complications[45,46]. Aldose reductase 
is the first and rate-limiting enzyme of the polyol pathway 
that catalyzes the reduction of glucose to sorbitol using 
NADPH as a cofactor[47]. This aldose reductase-catalyzed 
reaction is favoured under the hyperglycemic condition 
that characterizes T2D, and is believed to be the metabolic 
bases for diabetic complications in complication-prone 
tissues with high aldose reductase activity such as the 
eye, kidney, heart and nerves[48]. Previous studies have 
provided evidence for the involvement of aldose reductase 
in diabetic complications such as neuropathy, retinopathy, 
nephropathy and cataract[47,49]. In this study, both M. indica 
and M. urens seeds extracts displayed a dose-dependent 
inhibition of aldose reductase activity, suggesting that both 
plants have the potential to mitigate the complications 
of T2D. However, based on their IC50 values (0.71 mg/mL 
and 1.13 mg/mL for M. indica and M. urens, respectively), 
M. indica was more potent in inhibiting aldose reductase 
activity than M. urens. This aldose reductase inhibitory 
effect of the extracts could be attributed to their flavonoids; 
the reason being that flavonoids have been reported to 
function as anti-diabetic complications agents due to their 
antioxidant and free radical scavenging activities[9].
   Lipid peroxide-mediated tissue damages have been 
reported in T2D[50]. The peroxidation of lipids disrupts the 
fluidity and permeability of the membrane leading to the 
oxidative damage of unsaturated fatty acids components 
of biological membranes. In this study, lipid peroxidation 
in rat pancreas homogenate was induced with Fe2
+
. The 
accumulation of Fe2+ in the acinar cells and in the islets 
of Langerhan, results in the oxidative destruction of the 
β-cells of the pancreas associated with DM[51]. Therefore the 
ability of M. indica and M. urens extracts to inhibit Fe2
+
-
induced lipid peroxidation in rat pancreas homogenate is 
an indication that both extracts could mitigate the oxidative 
damage of the pancreas cells in T2D. Comparatively, M. 
indica with a lower IC50 had a stronger inhibitory potential 
against rat pancreas lipid peroxidation potential than M. 
urens.
   The predominance of pharmacologically important 
flavonoids and phenolic acids in the extracts of M. indica 
and M. urens seeds could be responsible for the inhibitory 
effect of the extracts against the activities of α-amylase, 
α-glucosidase and aldose reductase, as well as lipid 
peroxidation observed in this study. Thus, the inhibition of 
the activities of these carbohydrate-metabolizing enzymes 
by the extracts may be a possible mechanism of action 
supporting their use for the management of hyperglycemia 
and its associated complications in T2D. Comparatively, M. 
indica may be more pharmacologically potent in inhibiting 
the activities these enzymes than M. urens.
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Comments 
Background
   Diabetes-specific microvascular disease is a leading 
cause of blindness, renal failure and nerve damage. Four 
main molecular mechanisms have been implicated in 
glucose-mediated vascular damage. All seems to reflect a 
single hyperglycaemia-induced process of overproduction 
of superoxide by the mitochondrial electron-transport 
chain. This integrating paradigm provides a new 
conceptual framework for future research and drug 
discovery. Therefore, there is need of identifying novel 
and potent sources of phenolic compounds with inhibitory 
activity against key enzymes involved in complication of 
T2D.
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Research frontiers
   The present study reveals the presence of major flavonoids 
and phenolic acids with pharmacological importance, such 
as gallic acid, chlorogenic acid, caffeic acid, ellagic acid, 
catechin, rutin, quercitrin, quercetin and kaempferol and 
potential inhibitory activity (in vitro) of extracts of both 
the seeds against α-amylase, α-glucosidase and aldose 
reductase activities in a dose-dependent manner.
Related reports
   Dietary phytochemicals, of which polyphenols form a 
considerable part, may affect the risk of obesity-associated 
chronic diseases such as T2D. Fruits, vegetables, berries, 
beverages and herbal medicines have been reported to be 
widely used against various ailments ranging from obesity 
to diabetes in the traditional medicine. Besides, there is 
available evidence in the literature for phenolic compounds 
to be associated with antioxidant activity and may modify 
imbalanced lipid and glucose homeostasis thereby reducing 
the risk of the metabolic syndrome and T2D complications.
Innovations and breakthroughs
   Seeds of M. indica  and M. urens  are currently 
underutilized as compared to their potential health 
beneficial effects. In the present study, authors have 
demonstrated the potential role of underutilized seeds in 
managing hyperglycemia and preventing the complications 
associated with it in T2D through the inhibitory activity 




   From the literature survey it has been found that the 
studied seeds are safe to humans. This scientific study 
supports and suggests the use of these seeds as an excellent 
source of pharmacologically important flavonoids and 
phenolic acids in nutraceutical, food and medicinal 
industries.
Peer review
   This is a valuable research work in which authors have 
demonstrated the potential inhibitor against the activities 
of α-amylase, α-glucosidase and aldose reductase, as 
well as lipid peroxidation. Reverse phase chromatographic 
quantification of the major flavonoids and phenolic acids 
in the seeds extracts was carried out using HPLC-DAD. The 
inhibitory activities of the extracts against α-amylase and 
α-glucosidase were estimated using soluble starch and 
PNPG as their respective substrates. Inhibition of aldose 
reductase activity was assayed using partially purified 
lens homogenate of normal male rat as source of enzyme; 
inhibition of Fe2
+
-induced lipid peroxidation by extracts 
was tested in rat pancreas homogenate. In addition, M. 
indica may be more pharmacologically potent in inhibiting 
the activities these enzymes than M. urens.
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